MSKCC Commack is a clinical research site located in Commack, New York, United States 11725.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
MSKCC Commack has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, Metastatic Castrate-sensitive Prostate Cancer.
Sponsors: Genentech, Inc., Hoffmann-La Roche, Janssen Research & Development, LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Commack
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MSKCC Commack has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MSKCC Commack has 4 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, Metastatic Castrate-sensitive Prostate Cancer.
MSKCC Commack has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.